A regulatory table can look comprehensive because it contains companies, brands, offerings and several domains. That breadth does not mean every item in a row answers every product question. For someone evaluating a NuSTAR provider claim, the central task is to identify what the table actually states and which relationships a reader might be adding through inference.
Respect the structure of the row #
Read the column headings and any merged cells. A legal entity can have multiple brands or offerings associated with a row. The placement of several terms near one another does not necessarily allocate every offering to each printed address. If a table continues onto another page, inspect the layout so a continuation is not mistaken for a new entity or product assignment.
PAGCOR’s administrator list as of October 29, 2026 includes footnotes affecting interpretation. Its asterisk denotes offerings that have yet to commence commercial operations. That qualification should travel with a summary of the affected offering. It is not permission to describe all row contents as live, nor does it apply indiscriminately to every other entry.
Separate identity from catalogue detail #
The administrator’s NuSTAR entry and the resort-associated Casino Maxx entry belong to separate documents and legal entities. Their exact details are set out in the identity guide. Neither identity record should be borrowed to validate an unrelated product page. Keeping them separate is necessary, but separation alone still does not establish any provider relationship.
Suppose a writer sees an online-gaming category in a regulator table and fills an article with familiar provider names. The category may be correctly quoted while the catalogue is invented. A broad regulatory description cannot supply the missing provider-by-provider evidence. The same problem occurs when a writer assumes that a provider used by one platform must be available on another.
Ask a source to answer its own question #
The October lists were retrieved November 11, 2026. They support dated observations about their contents, not a universal statement about live products on a later day. They also do not substantiate payment methods, processing times, bonuses or independent publisher accreditation. Those assertions require different evidence and should not be appended to a row quotation as though the regulator supplied them.
For the JILI question, record the narrower conclusion: the cited operator lists do not establish that connection for PODEC’s NuSTAR. A relevant next source would explicitly identify the parties and service involved. Reading the table faithfully is valuable precisely because it prevents an official source from being made to endorse claims it never addresses.